101 related articles for article (PubMed ID: 3668854)
21. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
[TBL] [Abstract][Full Text] [Related]
22. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans.
Mays DC; Camisa C; Cheney P; Pacula CM; Nawoot S; Gerber N
Clin Pharmacol Ther; 1987 Dec; 42(6):621-6. PubMed ID: 3690940
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
[TBL] [Abstract][Full Text] [Related]
24. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
Fruncillo RJ; Kozin SH; DiGregorio GJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
[TBL] [Abstract][Full Text] [Related]
25. Changes in the metabolism of three model substrates catalysed by different P450 isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat.
Tanaka E; Ishikawa A; Misawa S
Xenobiotica; 1995 Nov; 25(10):1111-8. PubMed ID: 8578767
[TBL] [Abstract][Full Text] [Related]
26. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic characteristics of drugs in experimental splenectomy].
Krakovskiĭ ME; Ashirmetov AKh
Farmakol Toksikol; 1988; 51(2):98-9. PubMed ID: 3378618
[TBL] [Abstract][Full Text] [Related]
28. Hexobarbital blood levels and effects on EEG in the presence and absence of caffeine.
Milon H; Atkinson J
Arzneimittelforschung; 1979; 29(11):1724-7. PubMed ID: 120744
[TBL] [Abstract][Full Text] [Related]
29. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
Billings RE
Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
[TBL] [Abstract][Full Text] [Related]
30. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
Beach CA; Mays DC; Sterman BM; Gerber N
J Pharmacol Exp Ther; 1985 Apr; 233(1):18-23. PubMed ID: 3981454
[TBL] [Abstract][Full Text] [Related]
31. Disposition of hexobarbital enantiomers in the rat.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Drug Metab Dispos; 1983; 11(5):489-93. PubMed ID: 6138236
[TBL] [Abstract][Full Text] [Related]
32. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Yu WK; Wells PG
Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
[TBL] [Abstract][Full Text] [Related]
33. Studies on 8-methoxypsoralen tolbutamide interactions in vitro and in vivo.
Bevilacqua R; Baccichetti F; Gaion RM
Farmaco; 1991 Apr; 46(4):579-92. PubMed ID: 1930554
[TBL] [Abstract][Full Text] [Related]
34. Toxicology and Carcinogenesis Studies of 8-Methoxypsoralen (CAS No. 298-81-7) in F344/N Rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Jul; 359():1-130. PubMed ID: 12695782
[TBL] [Abstract][Full Text] [Related]
35. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM
Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589
[TBL] [Abstract][Full Text] [Related]
36. Phase I and phase II xenobiotic biotransformation in different inbred strains of rats: study in immobilized perfused hepatocytes.
Hynie S; Kren V; Mráz M; Farghali H
Folia Biol (Praha); 1998; 44(4):127-32. PubMed ID: 10732701
[TBL] [Abstract][Full Text] [Related]
37. Effect of cyclosporine A on cytochrome P-450-mediated drug metabolism in the partially hepatectomized rat.
Provencher SJ; Demers C; Bastien MC; Villeneuve JP; Gascon-Barré M
Drug Metab Dispos; 1999 Apr; 27(4):449-55. PubMed ID: 10101139
[TBL] [Abstract][Full Text] [Related]
38. Inactivation and induction of cytochrome P-450 by various psoralen derivatives in rats.
Letteron P; Descatoire V; Larrey D; Tinel M; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Aug; 238(2):685-92. PubMed ID: 3735138
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
Wamer W; Giles A; Kornhauser A
Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
[TBL] [Abstract][Full Text] [Related]
40. [Effect of vephylline on hexobarbital metabolism after single and multiple administrations].
Mincheva M; Chanade A
Eksp Med Morfol; 1989; 28(1):19-22. PubMed ID: 2743925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
